Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on September 24, 2025, that it repurchased 400,000 of its Ordinary Shares on September 23, 2025, at a price of $1.485 per share. These shares will be held in treasury. Following the purchase, the company's issued Ordinary Share capital is 345,967,440, with 16,993,791 shares held in treasury, resulting in total voting rights of 328,973,649. The buyback was authorized by shareholders in June 2025, permitting the repurchase of up to 14.99% of Ordinary Shares. The company intends to hold any repurchased shares in treasury and has appointed Deutsche Numis as its broker for these transactions.

Disclaimer*

UK 100

Latest directors dealings